Agilent Technologies Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Agilent Technologies Inc in the third quarter 2026?
Agilent Technologies inc achieved a return on average equity (ROE) of 41.99 % in its third quarter 2026, this is above A's average return on equity of 21.72%.
Agilent Technologies Inc s equity during the 12 months ending in the third quarter 2026 are valued at $3 billion

ROE fell compared to the second quarter 2026, despite the net income growth of 6.78% from the second quarter 2026.

Within the Laboratory Analytical Instruments industry Agilent Technologies inc achieved the highest return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 628, from total ROE ranking in the second quarter 2026 at 637.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jul 31 2026) III. Quarter	(Apr 30 2026) II. Quarter	(Jan 31 2026) I. Quarter	(Oct 31 2025) IV. Quarter	(Jul 31 2025) III. Quarter
Y / Y Equity Change	15.59 %	-	-	14.29 %	-
Y / Y Net Income Change	7.74 %	57.67 %	-4.09 %	23.65 %	19.15 %
Net Income (TTM) in Millions	1,440	1,414	1,290	1,303	1,220
Return On Equity (TTM)	41.99 %	44.45 %	40.8 %	41.86 %	42.04 %
A's Total Ranking	# 628	# 637	# 508	# 570	# 441
Equity (TTM) in Millions	7,363	-202	-184	6,741	6,370
Seq. Equity Change	-	-	-	5.82 %	-
Seq. Net Income Change	6.78 %	11.15 %	-29.72 %	29.17 %	56.28 %

Back to A Management Effectiveness >> A's 5 Years Annual ROE >> Compare A ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 1
Sector	# 45
Overall	# 628

Return On Equity Statistics
High	Average	Low
84.33 %	21.72 %	-1.24 %
(Oct. 31, 2006)		(Oct. 31, 2009)

A Annual Return On Equity	(Oct 31 2025) 2025	(Oct 31 2024) 2024	(Oct 31 2023) 2023	(Oct 31 2022) 2022	(Oct 31 2021) 2021
Total Equity in Millions	6,741	5,898	5,845	5,305	5,389
Y / Y Equity Change	14.29 %	0.91 %	10.18 %	-1.56 %	10.59 %
Net Income in Millions	1,303	1,289	1,240	1,254	1,210
Y / Y Net Income Change	1.09 %	3.95 %	-1.12 %	3.64 %	68.29 %
Return On Equity	19.33 %	21.85 %	21.21 %	23.64 %	22.45 %

Back to A Management Effectiveness >> A's 5 Years Annual ROE >> Compare A ROE to its Competitors

Annual Roe Comment

In 2025 ROE fell to 19.33 %, despite net income growth.

More Return On Equity Ratios
Laboratory Analytical Instruments Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
A's' Return on Equity at Yahoo Finance
A's Roe Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for A's Competitors
Subscribers only: Roe for Agilent Technologies Inc 's Suppliers
Subscribers only: Return On Equity for A's Customers

Companies with similar Return On Equity at Jul 31 2026, within Healthcare Sector	ROE
Medpace Holdings Inc	110.15 %
Pulmatrix Inc	108.83 %
Arbutus Biopharma Corp	106.04 %
Rigel Pharmaceuticals Inc	96.49 %
Exelixis Inc	93.62 %
Alnylam Pharmaceuticals Inc	93.61 %
Eli Lilly And Company	92.54 %
Amgen Inc	89.32 %
Q32 Bio Inc	76.88 %
3m Company	76.55 %
Oramed Pharmaceuticals Inc	73.03 %
Tg Therapeutics Inc	72.30 %
Idexx Laboratories Inc	71.96 %
Elite Pharmaceuticals Inc	71.10 %
Zoetis Inc	68.87 %
Rallybio Corporation	68.56 %
Earth Science Tech Inc	66.17 %
Aurinia Pharmaceuticals Inc	59.00 %
Vaxart Inc	53.04 %
Qhslab Inc	51.21 %
Tenet Healthcare Corp	50.64 %
Nrc Health	48.29 %
Concentra Group Holdings Parent Inc	48.13 %
Bristol myers Squibb Company	46.65 %
Agilent Technologies inc	41.99 %
Eton Pharmaceuticals Inc	40.13 %
Adma Biologics Inc	39.59 %
Dexcom Inc	36.25 %
Transmedics Group Inc	33.37 %
Arcutis Biotherapeutics Inc	32.92 %

Date modified: 2026-09-26T07:19:38+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.